Conmed Corp (CNMD) Tops Q4 EPS by 6c; Boosts FY12 Outlook; Guides Q112
Conmed Corp (NASDAQ: CNMD) reported Q4 EPS of $0.46, $0.06 better than the analyst estimate of $0.40. Revenue for the quarter came in at $185.6 million versus the consensus estimate of $184.97 million.
Conmed Corp sees FY2012 EPS of $1.75-$1.88, versus prior guidance of $1.60-$1.70 and the consensus of $1.75. Conmed Corp sees FY2012 revenue of $780-$790 million, versus prior guidance of $745-$755 million and the consensus of $760.2 million.
Conmed Corp sees Q1 2012 EPS of $0.42-$0.47, versus the consensus of $0.42. Conmed Corp sees Q1 2012 revenue of $190-$195 million, versus the consensus of $196.0 million.
For earnings history and earnings-related data on Conmed Corp (CNMD) click here.
Conmed Corp sees FY2012 EPS of $1.75-$1.88, versus prior guidance of $1.60-$1.70 and the consensus of $1.75. Conmed Corp sees FY2012 revenue of $780-$790 million, versus prior guidance of $745-$755 million and the consensus of $760.2 million.
Conmed Corp sees Q1 2012 EPS of $0.42-$0.47, versus the consensus of $0.42. Conmed Corp sees Q1 2012 revenue of $190-$195 million, versus the consensus of $196.0 million.
For earnings history and earnings-related data on Conmed Corp (CNMD) click here.